Gene editing therapeutics based on mRNA delivery
Advanced Drug Delivery Reviews · 2023-09 · 200 · 115026
DOI: 10.1016/j.addr.2023.115026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-09. Verfasst von Juliana Popovitz und 5 weiteren Autor:innen. Beteiligte Einrichtung: GenEdit, 681 Gateway Blvd., South San Francisco, CA 94080, USA. Hauptthemen laut MEDLINE: Gene Editing, Gene Transfer Techniques. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 110 Literaturangaben. Gefördert von: NIMH NIH HHS, NIAID NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
The field of gene editing has received much attention in recent years due to its immense therapeutic potential. In particular, gene editing therapeutics, such as the CRISPR-Cas systems, base editors, and other emerging gene editors, offer the opportunity to address previously untreatable disorders. This review aims to summarize the therapeutic applications of gene editing based on mRNA delivery. We introduce gene editing therapeutics using mRNA and focus on engineering and improvement of gene editing technology. We subsequently examine ex vivo and in vivo gene editing techniques and conclude with an exploration of the next generation of CRISPR and base editing systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- GenEdit, 681 Gateway Blvd., South San Francisco, CA 94080, USA.
- Department of Bioengineering, University of California, Berkeley, CA 94720, USA; Innovative Genomics Institute, 2151 Berkeley Way, Berkeley, CA 94704, USA.
- Department of Bioengineering, University of California, Berkeley, CA 94720, USA; Innovative Genomics Institute, 2151 Berkeley Way, Berkeley, CA 94704, USA. Electronic address: nmurthy@berkeley.edu.
- GenEdit, 681 Gateway Blvd., South San Francisco, CA 94080, USA. Electronic address: lee@genedit.com.
Förderung
- NIMH NIH HHS
- NIAID NIH HHS
- NIBIB NIH HHS
- NIDA NIH HHS
- NINDS NIH HHS
- National Institutes of Health
- Cystic Fibrosis Foundation
- Innovative Genomics Institute
Zitieren
APA
Popovitz, J., Sharma, R., Hoshyar, R., Soo Kim, B., Murthy, N., & Lee, K. (2023). Gene editing therapeutics based on mRNA delivery. Advanced Drug Delivery Reviews, 200, 115026. https://doi.org/10.1016/j.addr.2023.115026
Vancouver
Popovitz J, Sharma R, Hoshyar R, Soo Kim B, Murthy N, Lee K. Gene editing therapeutics based on mRNA delivery. Advanced Drug Delivery Reviews. 2023;200:115026. doi:10.1016/j.addr.2023.115026
BibTeX
@article{Popovitz2023,
author = {Popovitz, Juliana and Sharma, Rohit and Hoshyar, Reyhane and Soo Kim, Beob and Murthy, Niren and Lee, Kunwoo},
title = {Gene editing therapeutics based on mRNA delivery},
journal = {Advanced Drug Delivery Reviews},
year = {2023},
volume = {200},
pages = {115026},
doi = {10.1016/j.addr.2023.115026}
}
EUVIMED